BMJ Open (Jun 2022)
Rationale and design of a prospective study evaluating population pharmacokinetics and pharmacodynamics of rivaroxaban in Chinese patients with non-valvular atrial fibrillation
Abstract
No abstracts available.
BMJ Open (Jun 2022)